Acute Behavioural Disturbance (ABD) / agitation
Protocol · Psychiatry
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Severe agitation ± unusual strength, hot/sweating, tachycardia — a clinical picture (often toxicological), not a diagnosis; danger to self/others.
Assessment
Investigations
- Capillary glucose, SpO₂, temperature, obs (earliest safe moment)
- After control: VBG, FBC, U&E, LFT, troponin, CK, coagulation, tox/metabolic screen
- ECG (QT); continuous monitoring incl. capnography (ETCO₂)
Management
- Safety + de-escalation first; capacity (MCA); least-restrictive, shortest restraint; never prone/airway obstruction
- Sedate EARLY (prolonged struggle → hyperthermia + metabolic acidosis)
- Rapid tranquilisation (usually IM): ketamine 4 mg/kg IM OR droperidol 5–10 mg IM first-line; alt. midazolam 5–10 mg / lorazepam 4 mg / haloperidol 5 mg (± lorazepam 2 mg) IM
- Critical care/intubate if full first doses fail, ventilation fails, or persistent metabolic derangement/hyperthermia (ketamine induction; avoid sux + opioids)
Disposition
Treat the cause; correct glucose/electrolytes/acidosis, cool, watch rhabdomyolysis. Psych liaison/MHA if primary psychiatric. Frail/older: start low, go slow; avoid haloperidol/droperidol in Parkinson’s/Lewy-body.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.